Effects upon bone metabolism following total hip and total knee arthroplasty

Pathobiology

Volumn 70, Issue 1, 2002, Pages 26-33

  Schneider, Ulrich ^a   Schmidt Rohlfing, Bernhard ^a   Knopf, Udo ^b   Breusch, Steffen J ^b  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Arthroplasty; Bone resorption; Markers, biochemical

Indexed keywords

ALKALINE PHOSPHATASE; BIOCHEMICAL MARKER; CEMENT; DEOXYPYRIDINOLINE; PEPTIDE; PROCOLLAGEN;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BONE METABOLISM; CONTROLLED STUDY; FEMALE; HIP OSTEOARTHRITIS; HUMAN; KNEE OSTEOARTHRITIS; MAJOR CLINICAL STUDY; MALE; OSSIFICATION; OSTEOLYSIS; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TOTAL HIP PROSTHESIS; TOTAL KNEE REPLACEMENT; URINALYSIS;

ADULT; AGED; AGED, 80 AND OVER; ALKALINE PHOSPHATASE; AMINO ACIDS; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; BIOLOGICAL MARKERS; BONE RESORPTION; COLLAGEN; COLLAGEN TYPE I; FEMALE; HUMANS; MALE; MIDDLE AGED; OSTEOARTHRITIS, HIP; OSTEOARTHRITIS, KNEE; PEPTIDE FRAGMENTS; PEPTIDES; PROCOLLAGEN; PROSPECTIVE STUDIES; TIME FACTORS;

EID: 0036967964     PISSN: 10152008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000065999     Document Type: Article

References (31)

1. Akeson K: Biochemical markers of bone turnover. Acta Orthop Scand Suppl 1995;66:376-386.
2. Delmas PD: Biochemical markers of bone turnover for the clinical investigation of osteoporosis. Osteoporos Int 1993;1(suppl):81-86.
3. Del Campo MT, Gonzales-Casaus ML, Aguado P, Bernad M, Carrera F, Martinez ME: Effects of age, menopause and osteoporosis on free, peptide-bound and total pyridinium crosslink excretion. Osteoporos Int 1999;9: 449-454.
4. Ross PD, Knowlton W: Rapid bone loss is associated with increased levels of biochemical markers. J Bone Miner Res 1998;13:297-302.
5. Bettica P, Moro L, Robins SP, Taylor AK, Talbot J, Singer FR, Baylink DJ: Bone-resorption markers galactosyl hydroxylysine, pyridinium crosslinks, and hydroxyproline compared. Clin Chem 1992;38:2313-2318.
6. Erikson EF, Charles P, Melsen F, Mosekilde L, Risteli L, Risteli J: Serum markers of type I collagen formation and degradation in metabolic bone disease: Correlation with bone histomorphometry. J Bone Miner Res 1993;8:127-132.
7. Ohishi T, Takahashi M, Kushida K, Hoshino H, Tsuchikawa T, Naitoh K, Inoue T: Changes of biochemical markers during fracture healing. Arch Orthop Trauma Surg 1998;118:126-130.
8. Seibel MJ, Robins SP, Bilezikian JP: Urinary pyridinium crosslinks of collagen. Trends Endocrinol Metab 1992;3:263-270.
9. Robins SP, Woitge H, Hesley R, Ju J, Seyedin S, Seibel MJ: Direct, enzyme-linked immunoassay for urinary deoxypyridinoline as a specific marker for measuring bone resorption. J Bone Miner Res 1994;9:1643-1649.
10. Joerring S, Jensen LT: Changes in collagen metabolites in serum after cemented hip and knee arthroplasty. Arch Orthop Trauma Surg 1993; 112:139-141.
11. Thorsen K, Kristoffersson A, Hultdin J, Lorentzon R: Effects of moderate endurance exercise on calcium, parathyroid hormone, and markers of bone metabolism in young women. Calcif Tissue Int 1997;60:16-20.
12. Xu JW, Konttinen YT, Li TF, Waris V, Lassus J, Matucci-Cerinic M, Sorsa T, Santavirta S: Production of platelet-derived growth factor in aseptic loosening of total hip replacement. Rheumatol Int 1998;17:215-221.
13. Hernigou P, Intrator L, Bahrami T, Benussan A, Farcet JP: Interleukin-6 in the blood of patients with total hip arthroplasty without loosening. Clin Orthop 1999;366:147-154.
14. Merkel KD, Erdmann JM, McHugh KP, Abu-Amer Y, Ross FP, Teitelbaum SL: Tumor necrosis factor-α mediates orthopedic implant osteolysis. Am J Pathol 1999;154:203-210.
15. Kovacik MW, Gradisar IA, Haprian JJ, Alexander TS: Osteolytic indicators found in total knee arthroplasty synovial fluid aspirates. Clin Orthop 2000;379:186-194.
16. Schneider U, Breusch SJ, Termath S, Thomsen M, Brocai DRC, Niethard FU, Kasperk C: Increased urinary crosslink levels in aspetic loosening of total hip arthroplasty. J Arthroplasty 1998;13:687-692.
17. Antoniou J, Huk O, Zukor D, Eyre D, Alini M: Collagen crosslinked n-telopeptides as markers for evaluation of particulate osteolysis: A preliminary study. J Orthop Res 2000;18:64-67.
18. Pellengahr C, Mayer W, Dürr HR, Maier M, Müller P, Veihelmann A, Zysk S, Jansson V, Refior HJ: The value of desoxypyridinoline in the diagnostics of loosened arthroplasty. Arch Orthop Trauma Surg 2001;121:205-206.
19. Risteli J, Niemi S, Kauppila S, Melkko J, Risteli L: Collagen propeptides as indicators of collagen assembly. Acta Orthop Scand Suppl 1995; 66:183-188.
20. Melkko J, Niemi S, Risteli J: Radioimmunoassay of the carboxyterminal propeptide of human type I procollagen. Clin Chem 1990;36: 1328-1332.
21. Akeson K, Vergnaud P, Gineyts E, Delmas PD, Obrant KJ: Impairment of bone turnover in elderly women with hip fracture. Calcif Tissue Int 1993;53:162-169.
22. Seibel MJ, Cosman F, Shen V, Gordon S, Dempster DW, Ratcliff A, Lindsay R: Urinary hydroxypyridinium crosslinks of collagen as markers of bone resorption and estrogen efficacy in postmenopausal osteoporosis. J Bone Miner Res 1993;8:881-889.
23. Breusch SJ, Draenert Y, Draenert K: Anatomic basis of the cemented femur shaft. A comparative study of straight and anatomic design. Z Orthop 1998;136:554-559.
24. Delmas PD: Biochemical markers of bone turnover. Acta Orthop Scand Suppl 1995;266: 176-182.
25. Willert HG, Puls P: The reaction of bone to bone-cement in the replacement of the hip joint. Arch Orthop Unfallchir 1972;72:33-71.
26. Joerring S, Jensen LT, Andersen GR, Johansen JS: Types I and III procollagen extension peptides in serum respond to fracture in humans. Arch Orthop Trauma Surg 1992;111:265-267.
27. Meurer A, Lotz J, Eckardt A, Prellwitz W, Hei-ne J: Verlaufsbeobachtung des Kollagen- und Knochenstoffwechsels bei Patienten mit zementfreier Hüfttotalendoprothese. Z Orthop 1998:136:304-309.
28. Haukipuro K, Melkko J, Risteli L, Kairoalouma M, Risteli J: Synthesis of type I collagen in healing wounds in humans. Ann Surg 1991; 213:75-80.
29. Haukipuro K, Risteli L, Leppilathi J, Melkko J, Puranen J, Karialuoma MI, Risteli J: Responses of type-I- and type-III-collagen synthesis after replacemrnt of hip joint. J Surg Res 1995;58:443-448.
30. Schneider U, Termath S, Thomsen M, Brocai DRC, Niethard FU: Der Einsatz neuer biochemischer Marker in der Diagnostik aseptischer Hüftendoprothesenlockerungen. Z Orthop 1997;135:297-300.
31. Rosen HN, Dresner-Pollak R, Moses AC, Rosenblatt M, Zeind AJ, Clemens JD, Greenspan SL: Specificity of urinary excretion of cross-linked N-telopeptides of type I collagen as a marker of bone turnover. Calcif Tissue Int 1994;54:26-29.